Thomas Patrick Kelly J.D.
Net Worth

Last updated:

What is Thomas Patrick Kelly J.D. net worth?

The estimated net worth of Mr. Thomas Patrick Kelly J.D. is at least $8,990,166 as of 16 Feb 2024. He has earned $3,175,286 from insider trading and has received compensation worth at least $5,814,880 in Deciphera Pharmaceuticals, Inc..

What is the salary of Thomas Patrick Kelly J.D.?

Mr. Thomas Patrick Kelly J.D. salary is $726,860 per year as Executive Vice President, Chief Financial Officer & Treasurer in Deciphera Pharmaceuticals, Inc..

How old is Thomas Patrick Kelly J.D.?

Mr. Thomas Patrick Kelly J.D. is 54 years old, born in 1971.

What stocks does Thomas Patrick Kelly J.D. currently own?

As insider, Mr. Thomas Patrick Kelly J.D. owns shares in one company:

Company Title Shares Price per share Total value
Deciphera Pharmaceuticals, Inc. (DCPH) Executive Vice President, Chief Financial Officer & Treasurer 80,350 $0 $0

What does Deciphera Pharmaceuticals, Inc. do?

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.

DCPH logo
DCPH
Deciphera Pharmaceuticals, Inc.

Thomas Patrick Kelly J.D. insider trading

Deciphera Pharmaceuticals, Inc.

Mr. Thomas Patrick Kelly J.D. has made 28 insider trades between 2017-2024, according to the Form 4 filled with the SEC. Most recently he sold 3,010 units of DCPH stock worth $47,010 on 16 Feb 2024.

The largest trade he's ever made was exercising 350,946 units of DCPH stock on 2 Oct 2017. As of 16 Feb 2024 he still owns at least 80,350 units of DCPH stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 3,010 $15.62 $47,010
Sale
Common Stock 2,435 $14.47 $35,234
Sale
Common Stock 2,792 $15.37 $42,905
Sale
Common Stock 2,316 $12.02 $27,834
Sale
Common Stock 1,655 $14.4 $23,835
Sale
Common Stock 1,370 $15.1 $20,686
Sale
Common Stock 2,403 $21.24 $51,042
Sale
Common Stock 1,768 $10.75 $19,006
Sale
Common Stock 1,368 $9.05 $12,380
Sale
Common Stock 524 $48.87 $25,608
Option
Common Stock 3,000 $1.89 $5,670
Option
Stock Option (Right to Buy) 3,000 $1.89 $5,670
Sale
Common Stock 3,000 $1.89 $5,670
Option
Stock Option (Right to Buy) 3,000 $47.71 $143,127
Option
Common Stock 3,000 $47.71 $143,127
Sale
Common Stock 3,000 $47.71 $143,127
Sale
Common Stock 6,000 $14.9 $89,388
Option
Common Stock 6,000 $1.89 $11,340
Sale
Common Stock 6,000 $45.49 $272,946
Option
Stock Option (Right to Buy) 6,000 $1.89 $11,340
Sale
Common Stock 12,000 $55.32 $663,840
Option
Stock Option (Right to Buy) 12,000 $1.89 $22,680
Option
Common Stock 12,000 $1.89 $22,680
Option
Stock Option (Right to Buy) 4,359 $1.89 $8,239
Option
Common Stock 4,359 $1.89 $8,239
Sale
Common Stock 4,359 $57.59 $251,039
Option
Stock Option (Right to Buy) 7,641 $1.89 $14,441
Option
Common Stock 7,641 $1.89 $14,441
Sale
Common Stock 7,641 $58.48 $446,846
Option
Common Stock 40,000 $1.89 $75,600
Sale
Common Stock 40,000 $1.89 $75,600
Option
Stock Option (Right to Buy) 40,000 $1.89 $75,600
Option
Common Stock 3,750 $1.89 $7,088
Sale
Common Stock 3,750 $1.89 $7,088
Option
Stock Option (Right to Buy) 3,750 $1.89 $7,088
Option
Stock Option (Right to Buy) 11,250 $1.89 $21,263
Option
Common Stock 11,250 $1.89 $21,263
Sale
Common Stock 11,250 $35.11 $395,032
Sale
Common Stock 11,250 $41.95 $471,971
Option
Common Stock 11,250 $1.89 $21,263
Option
Stock Option (Right to Buy) 11,250 $1.89 $21,263
Option
Stock Option (Right to Buy) 177 $1.89 $335
Option
Common Stock 177 $1.89 $335
Sale
Common Stock 177 $1.89 $335
Sale
Common Stock 2,100 $1.89 $3,969
Option
Common Stock 2,100 $1.89 $3,969
Option
Stock Option (Right to Buy) 2,100 $1.89 $3,969
Sale
Common Stock 100 $25 $2,500
Option
Common Stock 100 $25 $2,500
Option
Stock Option (Right to Buy) 100 $25 $2,500
Option
Stock Option (Right to Buy) 1,373 $1.89 $2,595
Sale
Common Stock 1,373 $1.89 $2,595
Option
Common Stock 1,373 $1.89 $2,595
Option
Stock Option (Right to Buy) 13,500 $1.89 $25,515
Sale
Common Stock 13,500 $1.89 $25,515
Option
Common Stock 13,500 $1.89 $25,515
Option
Stock Option (Right to Buy) 1,500 $1.89 $2,835
Sale
Common Stock 1,500 $1.89 $2,835
Option
Common Stock 1,500 $1.89 $2,835
Option
Stock Option (Right to Buy) 5,000 $1.89 $9,450
Option
Common Stock 5,000 $1.89 $9,450
Sale
Common Stock 5,000 $1.89 $9,450
Option
Stock Option (Right to Buy) 350,946 $0.38 $132,658
Option
Stock Option (Right to Buy) 30,621 $1.89 $57,874

Deciphera Pharmaceuticals key executives

Deciphera Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: